Press release
Single-Cell Sequencing Market is expected to reach USD 15.8 billion by 2034, quadrupling
Single-Cell Sequencing
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72897
The technology has become critical in cancer research, immunology, neurology, stem cell biology, and drug discovery. Its ability to drive personalized medicine, biomarker discovery, and therapeutic innovation positions it as one of the most promising fields in life sciences.
In 2024, the global single-cell sequencing market is valued at USD 3.95 billion and is projected to reach USD 15.8 billion by 2034, growing at a CAGR of 14.8%.
Market Overview
• Market Size 2024: USD 3.95 billion
• Forecast 2034: USD 15.8 billion
• CAGR (2025-2034): 14.8%
Key Drivers
• Rising demand for personalized medicine and precision oncology.
• Technological advancements in next-generation sequencing (NGS) platforms.
• Increasing funding for genomics and life science research.
• Growing applications in immunology, neurology, and infectious diseases.
• Expansion of bioinformatics and AI for large-scale single-cell data analysis.
Key Challenges
• High cost of single-cell sequencing instruments and consumables.
• Data storage, processing, and interpretation complexities.
• Need for skilled bioinformaticians and advanced computational infrastructure.
• Regulatory and ethical concerns in clinical genomics.
Leading Players
10x Genomics, Illumina Inc., Becton Dickinson (BD) Biosciences, Fluidigm Corporation (now Standard BioTools), Mission Bio, QIAGEN, Takara Bio, Thermo Fisher Scientific, NanoString Technologies, and Oxford Nanopore Technologies.
Segmentation Analysis
By Technology
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarray
• Mass Spectrometry
• Others
By Application
• Cancer Research & Precision Oncology
• Immunology & Infectious Diseases
• Neurology & Stem Cell Research
• Drug Discovery & Development
• Others (microbiology, rare disease research)
By End User
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Laboratories
• Contract Research Organizations (CROs)
Summary:
Cancer research is the largest segment, driven by demand for precision oncology and biomarker discovery, while immunology and infectious disease applications are rapidly expanding.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72897/single-cell-sequencing-market
Regional Analysis
• North America
Largest market, driven by high R&D investments, advanced genomics infrastructure, and adoption of precision medicine in the U.S.
• Europe
Strong presence of academic research, with Germany, the UK, and France leading adoption in oncology and immunology studies.
• Asia-Pacific
Fastest-growing region, fueled by genomics research initiatives in China, Japan, South Korea, and India. Government funding and biotechnology investments are driving adoption.
• Middle East & Africa
Gradual uptake, with growth opportunities in academic research collaborations and emerging biotech hubs.
• Latin America
Brazil and Mexico drive adoption in cancer and infectious disease research, supported by regional genomics projects.
Summary:
North America leads in adoption and research output, while Asia-Pacific is expected to grow fastest due to strong investments in genomics and precision medicine initiatives.
Market Dynamics
Growth Drivers
1. Increasing demand for precision medicine and targeted therapies.
2. Expansion of cancer and immunology research applications.
3. Technological advancements in sequencing and bioinformatics.
4. Growing funding and collaborations in genomics research.
5. Rising adoption of single-cell RNA sequencing (scRNA-seq) in drug development.
Challenges
• High cost of sequencing platforms and consumables.
• Data complexity and bioinformatics bottlenecks.
• Ethical and regulatory concerns in clinical genomics.
• Limited standardization across platforms and workflows.
Latest Trends
• Emergence of multi-omics approaches integrating genomics, transcriptomics, and proteomics.
• Use of AI and machine learning for large-scale single-cell data interpretation.
• Development of portable sequencing platforms for point-of-care genomics.
• Increasing partnerships between academic institutions and biopharma companies.
• Growth of single-cell epigenomics and spatial transcriptomics.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72897
Competitor Analysis
Key Players
• 10x Genomics
• Illumina Inc.
• BD Biosciences
• Fluidigm (Standard BioTools)
• Mission Bio
• QIAGEN
• Takara Bio
• Thermo Fisher Scientific
• NanoString Technologies
• Oxford Nanopore Technologies
Competitive Landscape
The market is dynamic and innovation-driven, with companies like 10x Genomics and Illumina leading in sequencing platforms, while Thermo Fisher and QIAGEN expand consumables and bioinformatics solutions. Competition revolves around workflow integration, data analysis capabilities, and cost reduction strategies.
Conclusion
The single-cell sequencing market is at the forefront of genomics, drug discovery, and personalized medicine. Valued at USD 3.95 billion in 2024, the market is projected to reach USD 15.8 billion by 2034, growing at a CAGR of 14.8%.
Future opportunities lie in multi-omics, spatial transcriptomics, and clinical adoption of single-cell technologies. Companies that focus on scalability, affordability, and AI-enabled data interpretation will lead the next wave of growth in this rapidly evolving market.
This report is also available in the following languages : Japanese (単一細胞シーケンシング), Korean (단일 세포 시퀀싱), Chinese (单细胞测序), French (Séquençage de cellules uniques), German (Einzelzellsequenzierung), and Italian (Sequenziamento di singole cellule), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72897/single-cell-sequencing-market#request-a-sample
Our More Reports:
Automatic Gravity Feeder Market
https://exactitudeconsultancy.com/reports/75252/automatic-gravity-feeder-market
Non-Magnetic Connectors Market
https://exactitudeconsultancy.com/reports/75253/non-magnetic-connectors-market
Fast Resume Generation Platform Market
https://exactitudeconsultancy.com/reports/75254/fast-resume-generation-platform-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Single-Cell Sequencing Market is expected to reach USD 15.8 billion by 2034, quadrupling here
News-ID: 4207239 • Views: …
More Releases from Exactitude Consultancy
Microbial Fermentation CMO Market Forecast 2034, Leading the Growth with Lonza G …
Microbial fermentation contract manufacturing organizations (CMOs) are integral to the biopharmaceutical industry, offering scalable production platforms for biologics, biosimilars, enzymes, vaccines, and small molecules. Using microbial systems such as E. coli, yeast, and fungi, CMOs enable cost-effective, high-yield production of complex biomolecules.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72901
The market is witnessing robust growth due to the rising demand for biologics, biosimilars, and advanced therapies, coupled with pharmaceutical…
Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve …
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903
With the rise of antibiotic resistance, aging populations, and increased use of ventilators in…
Leading Companies in the Staphylococcus Aureus Market Forecast for 2034, Pfizer …
Staphylococcus aureus is a gram-positive bacterium that can cause a wide range of infections, from minor skin conditions to severe, life-threatening diseases such as pneumonia, sepsis, endocarditis, and osteomyelitis. Among its strains, methicillin-resistant Staphylococcus aureus (MRSA) remains a major global health threat, contributing to rising mortality rates and healthcare costs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72905
The growing prevalence of antimicrobial resistance (AMR) has intensified the need for…
Multidrug-Resistant Tuberculosis (MDR-TB) Market in 2034: Important Players Otsu …
Multidrug-resistant tuberculosis (MDR-TB) is one of the most pressing global health challenges, caused by Mycobacterium tuberculosis strains resistant to at least isoniazid and rifampicin, the two most powerful first-line TB drugs. MDR-TB poses a major threat to global TB eradication programs, with high treatment costs, complex regimens, and low success rates compared to drug-susceptible TB.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72907
The growing burden of MDR-TB, especially in…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
